Yx. Lin et al., Differences in the urinary excretion of 6-beta-hydroxycortisol/cortisol between Asian and Caucasian women, J CLIN PHAR, 39(6), 1999, pp. 578-582
The urinary ratio of 6-beta-hydroxycortisol/cortisol has been used as a non
invasive probe for human cytochrome P450 3A4 isoforms (CYP3A4). Ethnic-rela
ted differences in the ratio have not been evaluated. The aim of this study
was to determine if there are differences in the ratio between Asian and C
aucasian women over a menstrual cycle. First-morning urine samples were col
lected every other day starting from the second day of menstruation far a c
omplete menstrual cycle From 25 Asians and 26 Caucasian women who were 18 t
o 40 years old, healthy nonsmoking, and alcohol and drug free, including or
al contraceptives. Urine concentrations of 6-beta-hydroxycortisol and corti
sol were measured by high-pressure liquid chromatography (HPLC). For statis
tical analysis, three phases of the menstrual cycle were evaluated menstrua
tion (days 1-4), follicular or postmenstruation (days 6-10), and the luteal
phase (days 21-24) based on the average menstrual cycle (28 days). Statist
ical analysis was performed by an independent sample t-test using the Bonfe
rroni correction far repeated measures. Large intersubject and intrasubject
variations of the 6-beta-hydroxycortisol/cortisol ratios were absented dur
ing the menstrual cycles in bath ethnic groups. Asian women had a statistic
ally significant lower ratio than Caucasian women did for all three phases
of the menstrual cycle: 2.2 +/- 1.1 versus 5.1 +/- 3.5, 2.1 +/- 1.1 versus
6.0 +/- 4.9, and 2.8 +/- 1.6 versus 5.6 +/- 3.0 for the menstruation, folli
cular, and luteal phases, respectively. The two- to threefold lower 6-beta-
hydroxycortisol/cortisol ratios in Asian women suggest that Asian women may
have a lower CYP3A activity compared with Caucasian women. Differences in
ethnicity may mask potential gender-related effects if ethnic background is
not evaluated as a contributing factor. (C) 1999 the American College of C
linical Pharmacology.